These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30314274)

  • 1. Systemic Platelet-Activating Factor-Receptor Agonism Enhances Non-Melanoma Skin Cancer Growth.
    Romer E; Thyagarajan A; Krishnamurthy S; Rapp CM; Liu L; Fahy K; Awoyemi A; Sahu RP
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin.
    Sahu RP; Rezania S; Ocana JA; DaSilva-Arnold SC; Bradish JR; Richey JD; Warren SJ; Rashid B; Travers JB; Konger RL
    PLoS One; 2014; 9(11):e111608. PubMed ID: 25375862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.
    Sahu RP; Kozman AA; Yao Y; DaSilva SC; Rezania S; Martel KC; Warren SJ; Travers JB; Konger RL
    Carcinogenesis; 2012 Mar; 33(3):694-701. PubMed ID: 22223848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
    Sahu RP; Ferracini M; Travers JB
    Mediators Inflamm; 2015; 2015():820543. PubMed ID: 25922565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy generates platelet-activating factor agonists.
    Sahu RP; Harrison KA; Weyerbacher J; Murphy RC; Konger RL; Garrett JE; Chin-Sinex HJ; Johnston ME; Dynlacht JR; Mendonca M; McMullen K; Li G; Spandau DF; Travers JB
    Oncotarget; 2016 Apr; 7(15):20788-800. PubMed ID: 26959112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
    Zhang Q; Mousdicas N; Yi Q; Al-Hassani M; Billings SD; Perkins SM; Howard KM; Ishii S; Shimizu T; Travers JB
    J Clin Invest; 2005 Oct; 115(10):2855-61. PubMed ID: 16184199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species.
    Yao Y; Wolverton JE; Zhang Q; Marathe GK; Al-Hassani M; Konger RL; Travers JB
    J Immunol; 2009 Mar; 182(5):2842-8. PubMed ID: 19234179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.
    Thyagarajan A; Saylae J; Sahu RP
    Oncotarget; 2017 Jul; 8(30):49959-49972. PubMed ID: 28636992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.
    Sahu RP; Petrache I; Van Demark MJ; Rashid BM; Ocana JA; Tang Y; Yi Q; Turner MJ; Konger RL; Travers JB
    J Immunol; 2013 Mar; 190(5):2447-54. PubMed ID: 23355733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.
    Sahu RP
    Mol Med Rep; 2015 Jul; 12(1):394-400. PubMed ID: 25695262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists.
    Sahu RP; Turner MJ; DaSilva SC; Rashid BM; Ocana JA; Perkins SM; Konger RL; Touloukian CE; Kaplan MH; Travers JB
    Carcinogenesis; 2012 Jul; 33(7):1360-7. PubMed ID: 22542595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures.
    Anandi VL; Ashiq KA; Nitheesh K; Lahiri M
    Oncol Rep; 2016 Jan; 35(1):179-88. PubMed ID: 26531049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UVB Generates Microvesicle Particle Release in Part Due to Platelet-activating Factor Signaling.
    Bihl JC; Rapp CM; Chen Y; Travers JB
    Photochem Photobiol; 2016 May; 92(3):503-6. PubMed ID: 26876152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor.
    Melnikova V; Bar-Eli M
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):359-71. PubMed ID: 17721743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis.
    Hoesl C; Fröhlich T; Hundt JE; Kneitz H; Goebeler M; Wolf R; Schneider MR; Dahlhoff M
    Mol Oncol; 2019 Nov; 13(11):2476-2492. PubMed ID: 31580518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor.
    Travers JB; Edenberg HJ; Zhang Q; Al-Hassani M; Yi Q; Baskaran S; Konger RL
    J Invest Dermatol; 2008 Feb; 128(2):455-60. PubMed ID: 17928889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing.
    Ma X; Bazan HE
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1696-702. PubMed ID: 10845588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis.
    Hackler PC; Reuss S; Konger RL; Travers JB; Sahu RP
    Cancer Growth Metastasis; 2014; 7():27-32. PubMed ID: 25002816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor.
    Ishii S; Nagase T; Tashiro F; Ikuta K; Sato S; Waga I; Kume K; Miyazaki J; Shimizu T
    EMBO J; 1997 Jan; 16(1):133-42. PubMed ID: 9009274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.